vs

Side-by-side financial comparison of BLACKLINE, INC. (BL) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

BLACKLINE, INC. is the larger business by last-quarter revenue ($183.2M vs $127.1M, roughly 1.4× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 8.1%). BLACKLINE, INC. produced more free cash flow last quarter ($26.1M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 7.9%).

BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

BL vs ZLAB — Head-to-Head

Bigger by revenue
BL
BL
1.4× larger
BL
$183.2M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+9.0% gap
ZLAB
17.1%
8.1%
BL
More free cash flow
BL
BL
$52.8M more FCF
BL
$26.1M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
7.9%
BL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BL
BL
ZLAB
ZLAB
Revenue
$183.2M
$127.1M
Net Profit
$4.9M
Gross Margin
75.2%
51.0%
Operating Margin
3.7%
-54.6%
Net Margin
2.7%
Revenue YoY
8.1%
17.1%
Net Profit YoY
-91.3%
EPS (diluted)
$0.07
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BL
BL
ZLAB
ZLAB
Q4 25
$183.2M
$127.1M
Q3 25
$178.3M
$115.4M
Q2 25
$172.0M
$109.1M
Q1 25
$166.9M
$105.7M
Q4 24
$169.5M
$108.5M
Q3 24
$165.9M
$101.8M
Q2 24
$160.5M
$100.1M
Q1 24
$157.5M
$87.1M
Net Profit
BL
BL
ZLAB
ZLAB
Q4 25
$4.9M
Q3 25
$5.3M
$-36.0M
Q2 25
$8.3M
$-40.7M
Q1 25
$6.1M
$-48.4M
Q4 24
$56.4M
Q3 24
$17.2M
$-41.7M
Q2 24
$76.7M
$-80.3M
Q1 24
$10.8M
$-53.5M
Gross Margin
BL
BL
ZLAB
ZLAB
Q4 25
75.2%
51.0%
Q3 25
75.1%
59.5%
Q2 25
75.2%
60.6%
Q1 25
75.5%
63.6%
Q4 24
75.6%
61.5%
Q3 24
75.2%
64.1%
Q2 24
74.9%
64.9%
Q1 24
75.2%
61.4%
Operating Margin
BL
BL
ZLAB
ZLAB
Q4 25
3.7%
-54.6%
Q3 25
4.3%
-42.3%
Q2 25
4.4%
-50.3%
Q1 25
2.1%
-53.3%
Q4 24
3.7%
-62.6%
Q3 24
5.0%
-66.6%
Q2 24
1.4%
-76.0%
Q1 24
1.1%
-80.7%
Net Margin
BL
BL
ZLAB
ZLAB
Q4 25
2.7%
Q3 25
3.0%
-31.2%
Q2 25
4.8%
-37.3%
Q1 25
3.6%
-45.8%
Q4 24
33.3%
Q3 24
10.4%
-40.9%
Q2 24
47.8%
-80.2%
Q1 24
6.9%
-61.4%
EPS (diluted)
BL
BL
ZLAB
ZLAB
Q4 25
$0.07
$-0.05
Q3 25
$0.09
$-0.03
Q2 25
$0.13
$-0.04
Q1 25
$0.10
$-0.04
Q4 24
$0.79
$-0.09
Q3 24
$0.27
$-0.04
Q2 24
$0.22
$-0.08
Q1 24
$0.17
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BL
BL
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$390.0M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$332.3M
$715.5M
Total Assets
$1.8B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BL
BL
ZLAB
ZLAB
Q4 25
$390.0M
$689.6M
Q3 25
$419.9M
$717.2M
Q2 25
$459.1M
$732.2M
Q1 25
$479.5M
$757.3M
Q4 24
$885.9M
$779.7M
Q3 24
$725.3M
$616.1M
Q2 24
$616.6M
$630.0M
Q1 24
$331.4M
$650.8M
Stockholders' Equity
BL
BL
ZLAB
ZLAB
Q4 25
$332.3M
$715.5M
Q3 25
$328.3M
$759.9M
Q2 25
$414.0M
$791.7M
Q1 25
$417.9M
$810.8M
Q4 24
$446.7M
$840.9M
Q3 24
$367.9M
$667.7M
Q2 24
$325.8M
$704.2M
Q1 24
$279.8M
$762.2M
Total Assets
BL
BL
ZLAB
ZLAB
Q4 25
$1.8B
$1.2B
Q3 25
$1.7B
$1.2B
Q2 25
$1.8B
$1.2B
Q1 25
$1.8B
$1.2B
Q4 24
$1.8B
$1.2B
Q3 24
$1.7B
$985.3M
Q2 24
$1.9B
$987.4M
Q1 24
$2.1B
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BL
BL
ZLAB
ZLAB
Operating Cash FlowLast quarter
$26.7M
$-26.0M
Free Cash FlowOCF − Capex
$26.1M
$-26.7M
FCF MarginFCF / Revenue
14.2%
-21.0%
Capex IntensityCapex / Revenue
0.3%
0.5%
Cash ConversionOCF / Net Profit
5.46×
TTM Free Cash FlowTrailing 4 quarters
$161.5M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BL
BL
ZLAB
ZLAB
Q4 25
$26.7M
$-26.0M
Q3 25
$63.8M
$-32.0M
Q2 25
$32.3M
$-31.0M
Q1 25
$46.7M
$-61.7M
Q4 24
$43.8M
$-55.8M
Q3 24
$55.9M
$-26.8M
Q2 24
$40.7M
$-42.2M
Q1 24
$50.4M
$-90.1M
Free Cash Flow
BL
BL
ZLAB
ZLAB
Q4 25
$26.1M
$-26.7M
Q3 25
$63.3M
$-35.0M
Q2 25
$31.4M
$-33.9M
Q1 25
$40.8M
$-63.2M
Q4 24
$43.0M
$-58.4M
Q3 24
$55.5M
$-28.2M
Q2 24
$40.0M
$-42.9M
Q1 24
$50.1M
$-91.1M
FCF Margin
BL
BL
ZLAB
ZLAB
Q4 25
14.2%
-21.0%
Q3 25
35.5%
-30.4%
Q2 25
18.2%
-31.1%
Q1 25
24.4%
-59.9%
Q4 24
25.4%
-53.8%
Q3 24
33.5%
-27.7%
Q2 24
24.9%
-42.9%
Q1 24
31.8%
-104.5%
Capex Intensity
BL
BL
ZLAB
ZLAB
Q4 25
0.3%
0.5%
Q3 25
0.3%
2.6%
Q2 25
0.6%
2.6%
Q1 25
3.6%
1.5%
Q4 24
0.4%
2.4%
Q3 24
0.2%
1.3%
Q2 24
0.4%
0.7%
Q1 24
0.2%
1.1%
Cash Conversion
BL
BL
ZLAB
ZLAB
Q4 25
5.46×
Q3 25
12.07×
Q2 25
3.90×
Q1 25
7.72×
Q4 24
0.78×
Q3 24
3.24×
Q2 24
0.53×
Q1 24
4.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BL
BL

Subscription And Circulation$173.2M95%
Technology Service$10.0M5%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons